Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aurélien Olichon

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|October 9, 2007
Selection of genetically encoded fluorescent single domain antibodies engineered for efficient expression in Escherichia coliAurélien Olichon, Thomas Surrey
STAR Protocols|January 13, 2021
Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell lineNicolas Bery, Gilles Favre, Aurélien Olichon
Mabs|November 24, 2018
Nanobodies reveal an extra-synaptic population of SNAP-25 and Syntaxin 1A in hippocampal neuronsManuel Maidorn, Aurélien Olichon, Silvio O Rizzoli, et al.
Experimental Cell Research|September 11, 2007
OPA1 cleavage depends on decreased mitochondrial ATP level and bivalent metalsLaurent Baricault, Bruno Ségui, Laurie Guégand, et al.
The Journal of Biological Chemistry|January 2, 2003
Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosisAurélien Olichon, Laurent Baricault, Nicole Gas, et al.
Antibodies (Basel, Switzerland)|September 24, 2019
Selection and Characterization of a Nanobody Biosensor of GTP-Bound RHO ActivitiesLaura Keller, Nicolas Bery, Claudine Tardy, et al.
The International Journal of Biochemistry & Cell Biology|April 25, 2009
OPA1 functions in mitochondria and dysfunctions in optic nerveGuy Lenaers, Pascal Reynier, Ghizlane Elachouri, et al.
Yeast (Chichester, England)|September 19, 2002
What similarity between human and fission yeast proteins is required for orthology?Guy Lenaers, Laetitia Pelloquin, Aurélien Olichon, et al.
British Journal of Pharmacology|June 12, 2025
Bispecific nanobody® as a new pharmacological drug for the selective inhibition of Trypsin-3Melissa David, Anaïs Faihy, Corinne Rolland, et al.
Plos One|November 4, 2014
Generation of a single chain antibody variable fragment (scFv) to sense selectively RhoB activationPatrick Chinestra, Aurélien Olichon, Claire Medale-Giamarchi, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|October 9, 2007
Selection of genetically encoded fluorescent single domain antibodies engineered for efficient expression in Escherichia coliAurélien Olichon, Thomas Surrey
STAR Protocols|January 13, 2021
Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell lineNicolas Bery, Gilles Favre, Aurélien Olichon
Mabs|November 24, 2018
Nanobodies reveal an extra-synaptic population of SNAP-25 and Syntaxin 1A in hippocampal neuronsManuel Maidorn, Aurélien Olichon, Silvio O Rizzoli, et al.
Experimental Cell Research|September 11, 2007
OPA1 cleavage depends on decreased mitochondrial ATP level and bivalent metalsLaurent Baricault, Bruno Ségui, Laurie Guégand, et al.
The Journal of Biological Chemistry|January 2, 2003
Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosisAurélien Olichon, Laurent Baricault, Nicole Gas, et al.
Antibodies (Basel, Switzerland)|September 24, 2019
Selection and Characterization of a Nanobody Biosensor of GTP-Bound RHO ActivitiesLaura Keller, Nicolas Bery, Claudine Tardy, et al.
The International Journal of Biochemistry & Cell Biology|April 25, 2009
OPA1 functions in mitochondria and dysfunctions in optic nerveGuy Lenaers, Pascal Reynier, Ghizlane Elachouri, et al.
Yeast (Chichester, England)|September 19, 2002
What similarity between human and fission yeast proteins is required for orthology?Guy Lenaers, Laetitia Pelloquin, Aurélien Olichon, et al.
British Journal of Pharmacology|June 12, 2025
Bispecific nanobody® as a new pharmacological drug for the selective inhibition of Trypsin-3Melissa David, Anaïs Faihy, Corinne Rolland, et al.
Plos One|November 4, 2014
Generation of a single chain antibody variable fragment (scFv) to sense selectively RhoB activationPatrick Chinestra, Aurélien Olichon, Claire Medale-Giamarchi, et al.
Pageof 3